Astragaloside IV reduces the expression level of P-glycoprotein in multidrug-resistant human hepatic cancer cell lines

Molecular Medicine Reports

Volumn 9, Issue 6, 2014, Pages 2131-2137

  Wang, Pei Pei ^a,b   Xu, Du Juan ^b   Huang, Can ^c   Wang, Wei Ping ^a   Xu, Wen Ke ^a  

^a WANNAN MEDICAL COLLEGE   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c Anqing City Municipal Hospital   (China)

Author keywords

ABCB1; Astragaloside IV; Multidrug resistance; P glycoprotein

Indexed keywords

ASTRAGALOSIDE IV; FLUOROURACIL; MULTIDRUG RESISTANCE PROTEIN; VERAPAMIL; ANTINEOPLASTIC AGENT; ASTRAGALOSIDE A; HERBACEOUS AGENT; RHODAMINE 123; SAPONIN; TRITERPENE;

ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG POTENTIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIVER CANCER CELL LINE; MTT ASSAY; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; WESTERN BLOTTING; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; TOXICITY; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL TRANSPORT; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; DRUGS, CHINESE HERBAL; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; P-GLYCOPROTEIN; RHODAMINE 123; SAPONINS; TRITERPENES;

EID: 84899703842     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2074     Document Type: Article

References (27)

1. Gottesman MM, Fojo T and Bates SE: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2: 48-58, 2002. (Pubitemid 37328807)
2. Solazzo M, Fantappiè O, Lasagna N, Sassoli C, Nosi D and Mazzanti R: P-gp localization in mitochondria and its functional characterization in multiple drug-resistant cell lines. Exp Cell Res 312: 4070-4078, 2006. (Pubitemid 44834517)
3. Pluchino KM, Hall MD, Goldsborough AS, Callaghan R and Gottesman MM: Collateral sensitivity as a strategy against cancer multidrug resistance. Drug Resist Updat 15: 98-105, 2012.
4. Bark H and Choi CH: PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-kappaB. Cancer Chemother Pharmacol 65: 1131-1136, 2010.
5. Mistry P, Stewart AJ, Dangerfield W, et al: In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. Cancer Res 61: 749-758, 2001. (Pubitemid 32128642)
6. Dalton WS, Grogan TM, Meltzer PS, et al: Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 7: 415-424, 1989. (Pubitemid 19098134)
7. Li FR, Fu YY, Jiang DH, et al: Reversal effect of rosmarinic acid on multidrug resistance in SGC7901/Adr cell. J Asian Nat Prod Res 15: 276-285, 2013.
8. Lei Y, Tan J, Wink M, Ma Y, Li N and Su G: An isoquinoline alkaloid from the Chinese herbal plant Corydalis yanhusuo W.T. Wang inhibits P-glycoprotein and multidrug resistance-associate protein 1. Food Chem 136: 1117-1121, 2013.
9. Zhu H, Liu Z, Tang L, et al: Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistance human oral cancer(KB/VCR) cell. Eur J Pharmacol 696: 43-53, 2012.
10. Zhu L, Zhao L, Wang H, et al: Oroxylin A reverse P-glycoprotein mediated multidrug resistance of MCF7/ADR cells by G2/M arrest. Toxicol Lett 23: 107-115, 2013.
11. Song JZ, Yiu HH, Qiao CF, Han QB and Xu Hx: Chemical comparison and classification of Radix Astragali by determination of isoflavonoids and astragalosides. J Pharm Biomed Anal 47: 399-406, 2008.
12. Zhao LH, Ma ZX, Zhu J, Yu XH and Wang DP: Characterizaion of polysaccharide from Astragalus radix as the macrophage stimulator. Cell Immunol 271: 329-334, 2011.
13. Wang X, Xu X, Tao W, Li Y, Wang Y and Yang L: A systems biology approach to uncovering pharmacological synergy in herbal medicines with applications to cardiovascular disease. Evid Based Complement Alternat Med 2012: 519031, 2012.
14. Yuan YM, Gao JW, Shi Z, et al: Herb-drug pharmacokinetic interaction between radix astragali and pioglitazone in rats. J Ethnopharmacol 144: 300-304, 2012.
15. Huang C, Xu D, Xia Q, Wang P, Rong C and Su Y: Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II. J Pharm Pharmacol 64: 1741-1750, 2012.
16. Yu M, Ocana A and Tannock IF: Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit? Cancer Metastasis Rev 32: 211-227, 2013.
17. Leonard GD, Fojo T and Bates SE: The role of ABC transporters in clinical practice. Oncologist 8: 411-424, 2003. (Pubitemid 37238869)
18. Gui D, Huang J, Guo Y, et al: Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-kappaB-mediated inflammatory genes expression. Cytokine 61: 970-977, 2013.
19. Zhao J, Yang P, Li F, et al: Therapeutic effects of astragaloside IV on myocardial injuries: multi-target identification and network analysis. PLoS One 7: e44938, 2012.
20. Thiebaut F, Tsururo T, Hamada H, Gottesman MM, Pastan I and Willingharm MC: Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84: 7735-7738, 1987.
21. Eichhorn T and Efferth T: P-glycoprotein and its inhibition in tumors by phytochemical derived from Chinese herbs. J Ethnopharmacol 141: 557-570, 2012.
22. Gao A, Liang H, Wang XJ, et al: Reversal effects of two new milbemycin compounds on multidrug resistance in MCF-7/adr cells in vitro. Eur J Pharmacol 659: 108-113, 2011.
23. Hait WN and Yang JM: Clinical management of recurrent breast cancer: development of multidrug resistance (MDR) and strategies to circumvent it. Semin Oncol 32:S16 -S21, 2005.
24. Huang C, Xu D, Xia Q, Wang P, Rong C and Su Y: Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II. J Pharm Pharmacol 64: 1741-1750, 2012.
25. Shinoda C, Maruyama M, Fujishita T, et al: Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway. Int J Cancer 117: 21-31, 2005. (Pubitemid 41262756)
26. Zhou J, Liu M, Aneja R, Chandra R, Lage H and Joshi HC: Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase. Cancer Res 66: 445-452, 2006. (Pubitemid 43166053)
27. He D, Zhao XQ, Chen XG, et al: BIRB796, the inhibitor of p38 mitogen-activated protein kinase, enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cells. PLoS One 8: e54181, 2013.